Press Releases

Other News

May 30 2023
Lytix Biopharma’s innovative and unique solution emphasized in national clinical research report
May 12 2023
Hear our CEO, Øystein Rekdal, explaining how our technology has the potential to solve the major challenge in current cancer therapy
May 08 2023
"Norwegian cancer medicine is attracting attention", read article in TV2 news
Apr 12 2023
First patient dosed in Part 2 of Verrica Pharmaceuticals' Phase II study evaluating LTX-315
Mar 22 2023
Lytix Biopharma appoints Karsten Bruins Slot as Director Clinical Development